AletheiaHQ
DIR-B8-ZUF-2PQA/LVL 2·Guided ArbitrageGuided multi-step solo arbitrage producing a concrete deliverable. Requires basic commercial judgment. Examples: formatting extracted data into a $99 compliance checklist and cold-emailing 500 affected businesses; translating a buried scientific abstract into a viral short-form script monetised via affiliate links./85% confidence
Return to Directory

FOIA SBIR Human Subject Protocols into IRB Validation Package

Organization
NSF SBIR program funding medical device R&D with human subject components but no regulatory template support
Sector
SBIR microfluidic PIs facing imminent human subject research requirements
Location
Location unspecified
// Journalism// Curriculum Development// Biotech// Grant Writing// Compliance// Open-Source Intelligence// Health Policy & Regulation

Executive Context

NSF awarded DELEON TECHNOLOGIES $305K SBIR Phase I funding to develop a disposable microfluidic chip for urine analysis, creating a classic "SBIR Valley of Death" scenario where government-funded technical capability exists without commercial infrastructure for FDA clearance, manufacturing scale, or data monetization.

Catalyst / Timing

SBIR microfluidic projects involving human subject research (like DELEON's urine analysis) must navigate IRB approvals and FDA protocols but lack standardized templates - each PI reinvents the wheel at high cost and risk of rejection

Projected Yield

$1,995/package × 5 sales = $9,975 (minimum viable)

Structural Friction

• Vulnerability: SBIR microfluidic projects involving human subject research (like DELEON's urine analysis) must navigate IRB approvals and FDA protocols but lack standardized templates - each PI reinvents the wheel at high cost and risk of rejection • Capital yield: $1,995/package × 5 sales = $9,975 (minimum viable) • Resource capture: Proprietary template library validated against actual SBIR requirements • Influence capture: Authority position as the 'SBIR clinical validation' expert for microfluidic devices • Sovereignty yield: First-mover in niche regulatory template market for microfluidic SBIR projects • Required vectors: Vector: FOIA & Government Document Analysis, Vector: Clinical Research Protocol Writing

Required Capabilities

  • Vector: FOIA & Government Document Analysis

    Primary executor: Phase 1: FOIA Submission for Clinical Protocol: Submit FOIA request to NSF for DELEON TECHNOLOGIES SBIR Phase I proposal

  • Vector: Clinical Research Protocol Writing

    Supporting vector for: FOIA SBIR Human Subject Protocols into IRB Validation Package

Execution Protocol

Execution Protocol Locked

A one-time payment of $49 unlocks the exact wedge, required assets, and step-by-step execution parameters yours forever, no subscription.

This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.